Showing results (1631-1640 of 1,668) with videos related to

Sort By:
Pageof 167
Archives of Disease in Childhood|July 20, 2022
Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019-2021Helen Ratcliffe, K S Tiley, Nick Andrews, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 13, 2018
Fermented dairy products, diet quality, and cardio-metabolic profile of a Mediterranean cohort at high cardiovascular riskG Mena-Sánchez, N Babio, M Á Martínez-González, et al.
Annals of Neurology|December 9, 2020
Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19Marcos Fragiel, Òscar Miró, Pere Llorens, et al.
Journal of Epidemiology|April 7, 2020
Who Smokes in Europe? Data From 12 European Countries in the TackSHS Survey (2017-2018)Silvano Gallus, Alessandra Lugo, Xiaoqiu Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2025
Carbapenem-resistant Gram-negative bacilli bacteremia in Argentina (EMBARCAR): findings from a prospective, multicenter cohort studyJuan Pablo Balbuena, Ezequiel Cordova, Analia Mykietiuk, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Consumption of processed foods impairs memory function through dietary advanced glycation end-productsAnna M R Hayes, Molly E Klug, Madhav Sharma, et al.
Journal of Pediatric Surgery|March 19, 2019
Development of a multi-institutional registry for children with operative congenital lung malformationsShaun M Kunisaki, Jacqueline M Saito, Mary E Fallat, et al.
Cell|January 14, 2017
DNA Damage Signaling Instructs Polyploid Macrophage Fate in GranulomasLaura Herrtwich, Indrajit Nanda, Konstantinos Evangelou, et al.
Epilepsia Open|October 29, 2024
BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practiceVicente Villanueva, Esther González Villar, Alejandro Fernandez-Cabrera, et al.
Blood Cancer Journal|April 29, 2024
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progressionA Medina-Herrera, I Vazquez, I Cuenca, et al.
Pageof 167